Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 11°C (overcast clouds)
Topic Feed

BiotechStocks

Showing the latest stories and updates for this topic.
Monday Market Buzz: Key Stocks Defying Gravity, What's Driving the Surge?

Monday Market Buzz: Key Stocks Defying Gravity, What's Driving the Surge?
Beyond the Numbers: Oxford Industries' Q4 Story and Today's Market Movers

Beyond the Numbers: Oxford Industries' Q4 Story and Today's Market Movers
Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off

Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off
A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat

A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat
A Glimmer of Hope? Why Wall Street is Bullish on ImmunityBio (IBRX) After Key Saudi Approval

A Glimmer of Hope? Why Wall Street is Bullish on ImmunityBio (IBRX) After Key Saudi Approval
Navigating the Shifting Sands: An Investor's Roadmap Towards 2026

Navigating the Shifting Sands: An Investor's Roadmap Towards 2026
ArriVent BioPharma: Decoding the 'Cautious Buy' on Furmonertinib

ArriVent BioPharma: Decoding the 'Cautious Buy' on Furmonertinib
Unpacking Today's Market Buzz: What's Moving Before the Bell?

Unpacking Today's Market Buzz: What's Moving Before the Bell?
The Bells Toll: Market Closes on December 10, 2025, Amidst Mixed Signals

The Bells Toll: Market Closes on December 10, 2025, Amidst Mixed Signals
Virax Biolabs (VRAX) Stock Takes a Breather After a Wild Intraday Rally

Virax Biolabs (VRAX) Stock Takes a Breather After a Wild Intraday Rally
South Korea's Dazzling Stock Rally: A Rollercoaster Ride with Potential Pitfalls

South Korea's Dazzling Stock Rally: A Rollercoaster Ride with Potential Pitfalls
The Tale of Two Biotechs: Charting the Divergent Paths of Aptorum and Enliven Therapeutics

The Tale of Two Biotechs: Charting the Divergent Paths of Aptorum and Enliven Therapeutics
The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics

The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics
Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave
Two Biotech Stories, One Volatile Market: A Deep Dive into Gossamer and Precision

Two Biotech Stories, One Volatile Market: A Deep Dive into Gossamer and Precision
The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation

The Biotech Crossroads: Where Vor Biopharma and Liminatus Pharma Stand in the Race for Innovation
New Kids on the Block: Evommune & BilliontoOne Prep for Their Big Debut

New Kids on the Block: Evommune & BilliontoOne Prep for Their Big Debut
The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises

The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises
The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market

The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market
Momentum Mavericks: 5 Powerhouse Stocks Poised for Big Earnings Weeks Ahead

Momentum Mavericks: 5 Powerhouse Stocks Poised for Big Earnings Weeks Ahead
Market Movers Alert: Taysha Gene Therapies, Canaan, Ondas Holdings Skyrocket on Thursday's Trading!

Market Movers Alert: Taysha Gene Therapies, Canaan, Ondas Holdings Skyrocket on Thursday's Trading!
Goldman Sachs Unveils Exclusive List of 48 Companies Primed for Acquisition Across Key Sectors

Goldman Sachs Unveils Exclusive List of 48 Companies Primed for Acquisition Across Key Sectors
Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target

Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target
Summit Therapeutics Soars: Cancer Drug Ivonesimab Delivers Breakthrough Survival Gains, Igniting Retail Investor Frenzy

Summit Therapeutics Soars: Cancer Drug Ivonesimab Delivers Breakthrough Survival Gains, Igniting Retail Investor Frenzy
Unlocking Potential: Top 5 Biotech Stocks Riding a Wave of Momentum

Unlocking Potential: Top 5 Biotech Stocks Riding a Wave of Momentum
Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.

Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.
Load more..